Florfenicol sustained-release granules: an in vitro-in vivo correlation study in pigs

被引:1
|
作者
Yang, Wei-cong [1 ]
Liu, Zi-yao [1 ]
Zhang, Yun-xiao [1 ]
Yu, Yang [1 ]
Shen, Yue [1 ]
Xu, Ying [1 ]
Huang, Xian-hui [1 ,2 ]
机构
[1] South China Agr Univ, Coll Vet Med, Vet Pharmacol & Toxicol, 483 Wushan Rd, Guangzhou 510642, Peoples R China
[2] Natl Risk Assessment Lab Antimicrobial Resistance, Guangzhou 510642, Peoples R China
关键词
Pharmacokinetic; Oral delivery; In vitro-in vivo correlation; Pig; Florfenicol; ANTIBACTERIAL ACTIVITY; PHARMACOKINETICS; DISSOLUTION; BIOAVAILABILITY; NANOPARTICLES; HEALTHY; MODEL; PEG;
D O I
10.1186/s12917-023-03631-2
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
The objective of this study was to synthesize and characterize pharmaceutical characteristics of florfenicol sustained-release granules (FSRGs) in vitro and in vivo. FSRGs were synthesized using monostearate, polyethylene glycol 4000 and starch. In vitro dissolution profiles were studied using the rotating basket method in pH 1.2 HCl solution and pH 4.3 acetate buffer. Twenty-four male healthy LandracexYorkshire pigs were equally divided into three groups and administered a 20 mg/kg i.v bolus of florfenicol solution and dosed orally with FSRGs in the fasting and fed states. The Higuchi model was the best fit for the drug release profile in pH 1.2 and pH 4.3 media, and the mechanism of drug dissolution was governed by both diffusion and dissolution. We established a level A in vitro - in vivo correlation for FSRGs and the in vivo profile of the FSRGs can be estimated by the in vitro drug release.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Florfenicol sustained-release granules: an in vitro-in vivo correlation study in pigs
    Wei-cong Yang
    Zi-yao Liu
    Yun-xiao Zhang
    Yang Yu
    Yue Shen
    Ying Xu
    Xian-hui Huang
    BMC Veterinary Research, 19
  • [2] In Vitro-In Vivo Correlation of Tianeptine Sodium Sustained-Release Dual-Layer Tablets
    Lee, Ye-Ji
    Kim, Joo-Eun
    MOLECULES, 2022, 27 (09):
  • [3] Sustained-release of Cyclosporin A pellets: preparation, in vitro release, pharmacokinetic studies and in vitro-in vivo correlation in beagle dogs
    Jiang, Dongmei
    Zeng, Jin
    Zhu, Yuan
    Zhou, Guanghui
    Deng, Wenwen
    Xu, Ximing
    Yu, Jiangnan
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2016, 42 (07) : 1174 - 1182
  • [4] Preparation, optimization and in vitro-in vivo evaluation of Shunxin sustained release granules
    Dou, Yinghuan
    Li, Xuefeng
    Shi, Yanbin
    Zhang, Jiaying
    Yuan, Yang
    Zhou, Mengru
    Wei, Xiangxiang
    Zhang, Xiaoying
    CHINESE MEDICINE, 2019, 14 (01)
  • [5] DEVELOPMENT AND IN VITRO-IN VIVO EVALUATION OF A MULTIPARTICULATE SUSTAINED-RELEASE FORMULATION OF DILTIAZEM
    LI, SP
    FELT, RG
    DIPAOLO, LC
    HUANG, MY
    WILLIAMS, RO
    PHARMACEUTICAL RESEARCH, 1995, 12 (09) : 1338 - 1342
  • [6] In vitro-in vivo characterization of release modifying agents for parenteral sustained-release ketorolac formulation
    Puri, V
    Bansal, AK
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2004, 30 (06) : 619 - 626
  • [7] Correlation of in vitro-in vivo release rates for sustained release nevirapine implants in rats
    Chen, J
    Walters, K
    Ashton, P
    JOURNAL OF CONTROLLED RELEASE, 2005, 101 (1-3) : 357 - 358
  • [8] Design of experiment (DoE)-based formulation design of bepotastine sustained-release tablet and in vitro-in vivo pharmacokinetic correlation
    Jeon, Sang-Won
    Park, Jin-Hyun
    Kim, Joo-Eun
    Park, Young-Joon
    JOURNAL OF PHARMACEUTICAL INVESTIGATION, 2023, 53 (03) : 407 - 416
  • [9] Design of experiment (DoE)-based formulation design of bepotastine sustained-release tablet and in vitro-in vivo pharmacokinetic correlation
    Sang-Won Jeon
    Jin-Hyun Park
    Joo-Eun Kim
    Young-Joon Park
    Journal of Pharmaceutical Investigation, 2023, 53 : 407 - 416
  • [10] Development and In Vitro-In Vivo Evaluation of a Novel Sustained-Release Loxoprofen Pellet with Double Coating Layer
    Wan, Dongwei
    Zhao, Min
    Zhang, Jingjing
    Luan, Libiao
    PHARMACEUTICS, 2019, 11 (06):